Browsing by Author Vella Szijj, Janis

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 45 to 64 of 65 < previous   next >
Issue DateTitleAuthor(s)
2019Orphan drug policies in different countriesAbbas, Amar; Vella Szijj, Janis; Azzopardi, Lilian M.; Serracino-Inglott, Anthony
2021Perspectives of practices related to the implementation of the FMDAlmojero, Danielle Claire E.; Vella Szijj, Janis; Azzopardi, Lilian M.; Serracino-Inglott, Anthony
2023-05Post-graduate course in pharmaceutical and regulatory sciencesSerracino-Inglott, Anthony; Attard Pizzuto, Maresca; Sammut Bartolo, Nicolette; Vella Szijj, Janis; Azzopardi, Lilian M.
2019Practical liquid chromatography–tandem mass spectrometry method for the simultaneous quantification of amitriptyline, nortriptyline and their hydroxy metabolites in human serumMifsud Buhagiar, Luana; Sammut, Carmel; Chircop, Yana; Axisa, Kersty; Sammut Bartolo, Nicolette; Vella Szijj, Janis; Serracino-Inglott, Anthony; LaFerla, Godfrey
2020Predictors of inappropriate prescribing in patients with renal impairmentAntoniak, K. M.; Vella Szijj, Janis
2021Price of medicines in a small market country : a comparative approachKochova, Emilija; Vella Szijj, Janis; Azzopardi, Lilian M.
2023Proposal for setting up a forensic toxicology laboratoryGrima, Kimberly; Vella Szijj, Janis; Azzopardi, Lilian M.
2020Public perception of generic medicines in MaltaSammut Bartolo, Nicolette; Ignas, Louella Bianca; Wirth, Francesca; Attard Pizzuto, Maresca; Vella Szijj, Janis; Camilleri, Liberato; Serracino-Inglott, Anthony; Azzopardi, Lilian M.
2022QT shortening : a proarrhythmic safety surrogate measure or an inappropriate indicator of it?Tanti, Amy; Micallef, Benjamin; Vella Szijj, Janis; Serracino-Inglott, Anthony; Borg, John-Joseph
2018-11Rare diseases and orphan drug availability in MaltaAbbas, Amar; Vella Szijj, Janis; Serracino-Inglott, Anthony
2022Reflections on the use of cannabidiol for medicinal purposes and the views of healthcare professionalsCalleja, Abigail; Vella Szijj, Janis; Serracino-Inglott, Anthony
2023Risk management of medication errors : a novel conceptual frameworkDespott, Richard; Sultana, Janet; Camilleri, Liberato; Vella Szijj, Janis; Serracino Inglott, Anthony
2020The shift from class-based to online learning during COVID-19 : a student and academic perceptionSammut Bartolo, Nicolette; Attard Pizzuto, Maresca; Wirth, Francesca; Vella Szijj, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M.
2014A simple HPLC-UV method for the determination of clindamycin in human plasmaMifsud, Martina; Vella Szijj, Janis; Ferrito, Victor; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; Sammut Bartolo, Nicolette; LaFerla, Godfrey; Sammut, Carmel
2015A simple HPLC–UV method for the determination of ciprofloxacin in human plasmaVella Szijj, Janis; Busuttil, Francesca; Sammut Bartolo, Nicolette; Sammut, Carmel; Ferrito, Victor; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; LaFerla, Godfrey
2021Software validation in the pharmaceutical industrySammut, Chris; Vella Szijj, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M.
2018-11Structure activity relationship of drugs of abuseAxisa, Kersty; Vella Szijj, Janis; Serracino-Inglott, Anthony
2019Synthetic drugs of abuse exhibiting kinetic and non-kinetic toxicologyXuereb, Sarah; Vella Szijj, Janis; Azzopardi, Lilian M.
2022Therapeutic potential of cannabidiolCalleja, Abigail; Vella Szijj, Janis; Serracino-Inglott, Anthony
2021A three-year post-graduate Doctorate in Pharmacy course incorporating professional, experiential and research activities : a collaborative innovative approachVella Szijj, Janis; Attard Pizzuto, Maresca; Sammut Bartolo, Nicolette; Wirth, Francesca; Grech, Louise; Pham, Jennifer T.; Haaf-Mactal, Christina; Lau, Alan H.; Serracino-Inglott, Anthony; Azzopardi, Lilian M.